Samir E. Witta

Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines

Samir E. Witta, Robert M. Gemmill, Fred R. Hirsch et al. · Cancer Research · 2006 · 532 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

Samir E. Witta, Robert M. Jotte, Katrik Konduri et al. · Journal of Clinical Oncology · 2012 · 195 citations · Full text

Medicine, Oncology, Pharmacology +17

Baseline Gene Expression Predicts Sensitivity to Gefitinib in Non–Small Cell Lung Cancer Cell Lines

Christopher D. Coldren, Barbara A. Helfrich, Samir E. Witta et al. · Molecular Cancer Research · 2006 · 140 citations

Medicine, Oncology, Pharmacology +17

Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression

Rafał Dziadziuszko, Daniel T. Merrick, Samir E. Witta et al. · Journal of Clinical Oncology · 2010 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +13

Epidermal Growth Factor Receptor Messenger RNA Expression, Gene Dosage, and Gefitinib Sensitivity in Non–Small Cell Lung Cancer

Rafał Dziadziuszko, Samir E. Witta, Federico Cappuzzo et al. · Clinical Cancer Research · 2006 · 97 citations

Medicine, Genetics, Oncology +17